Address: 19th Floor, Asia Center Building 173/20 South Sathorn Road,Thungmahamek, Sathorn, Bangkok, 10120,Thailand
Tel: 66 2 739 7400
As a global biopharmaceutical company, our activities touch many people’s lives.
For patients and physicians, we provide medicines for some of the world’s most serious diseases. For the people who pay for healthcare, we work to make sure that our medicines offer real value for money. For our employees, we provide a culture in which they can feel appreciated, energised and rewarded for their contribution. For our shareholders, we aim to deliver value through our continued focus on innovation and running our business efficiently. For the wider community, we want to be valued for the contribution our medicines can make to society and trusted for the way in which we do business.
We work closely with all our stakeholders to understand their challenges and how we can combine our skills and resources to achieve a common goal: improved health.
Products and services
CV disease remains the greatest risk to life for adults, accounting for 17 million deaths worldwide each year.
In the West (i.e. Europe and North America) between 10-20% of adults suffer from GERD. The prevalence of GERD in Asia is lower, but increasing.
World demand for antibiotics remains high, due to escalating resistance and the increased risk of serious infections in both immunosuppressed patients and ageing populations.
Disorders of the central nervous system are the most significant disease burden in high income countries and is expected to grow substantially in other regions of the world, including Asia, as the standard of living increases.
Cancer claims over 7 million lives every year and the number continues to rise. Deaths are estimated to reach 12 million by 2030.
Chronic obstructive pulmonary disease is the fourth leading cause of death worldwide and further increases are anticipated. An estimated 300 million people suffer from asthma.